NSD1 and synovial sarcoma: This enrichment in neural and cellular development pathways reflects the cardinal features of SS (that is, overgrowth and developmental delay) and validates the utility of the DNAm signature to elucidate the functional, biological and molecular impact of NSD1 pathogenic variants.